Rentschler Biopharma, a global CDMO for biopharmaceuticals, and VarmX, a biotech company developing direct oral ...

Superwarfarins represent a class of long‐acting anticoagulant rodenticides that exert their effect through profound inhibition of vitamin K recycling, primarily by targeting vitamin K epoxide ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood ...

A potentially fatal disorder which causes blood clotting has been linked to a common cold, according to researchers from the University of North Carolina School of Medicine. The team found a ...

Blood has many functions and circulates throughout your body. As a result, problems with it can affect you in many ways. Some of those problems can stem from a blood disorder. These disorders can ...

To help diagnose von Willebrand disease or other bleeding disorders, a doctor will request various blood tests. These tests will measure the presence and activity of certain substances in the blood.

Patients with cancer are more likely to die from cardiovascular diseases, according to a study.The study, published in the ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Patients diagnosed with cancer are at a higher risk of dying from cardiovascular diseases (CVD), according to a new study ...